Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation (Q40380708)
Jump to navigation
Jump to search
scientific article published on 26 August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation |
scientific article published on 26 August 2005 |
Statements
1 reference
Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation (English)
1 reference
Hyae Gyeong Cheon
1 reference
Hyun Jeong Kwak
1 reference
Jin Sook Song
1 reference
Jun Young Heo
1 reference
Sung Don Yang
1 reference
Ji-Youn Nam
1 reference
26 August 2005
1 reference
1 reference
Identifiers
1 reference